These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 13002383)

  • 1. An antifungal polypeptide produced by Bacillus subtilis.
    BABAD J; PINSKY A; TURNER-GRAFF R; SHARON N
    Nature; 1952 Oct; 170(4328):618-9. PubMed ID: 13002383
    [No Abstract]   [Full Text] [Related]  

  • 2. An antifungal substance from a strain of B subtilis.
    NANDI P; SEN GP
    Nature; 1953 Nov; 172(4384):871-2. PubMed ID: 13111221
    [No Abstract]   [Full Text] [Related]  

  • 3. Classification of the antifungal antibiotics from Bacillus subtilis.
    SHARON N; PINSKY A; TURNER-GRAFF R; BABAD J
    Nature; 1954 Dec; 174(4443):1190-1. PubMed ID: 13223776
    [No Abstract]   [Full Text] [Related]  

  • 4. Mycobacillin, a new antifungal antibiotic produced by B. subtilis.
    MAJUMDAR SK; BOSE SK
    Nature; 1958 Jan; 181(4602):134-5. PubMed ID: 13493627
    [No Abstract]   [Full Text] [Related]  

  • 5. Two antifungal substances from Bacillus subtilis cultures.
    MICHENER HD; SNELL N
    Arch Biochem; 1949 Jun; 22(2):208-14. PubMed ID: 18131420
    [No Abstract]   [Full Text] [Related]  

  • 6. Bacillomycin; an antibiotic from Bacillus subtilis active against pathogenic fungi.
    LANDY M; WARREN GH
    Proc Soc Exp Biol Med; 1948 Apr; 67(4):539-41. PubMed ID: 18860010
    [No Abstract]   [Full Text] [Related]  

  • 7. Production of glutamyl polypeptide by Bacillus subtilis.
    THORNE CB; GOMEZ CG; NOYES HE; HOUSEWRIGHT RD
    J Bacteriol; 1954 Sep; 68(3):307-15. PubMed ID: 13201526
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of mycobacillin, an antifungal polypeptide antibiotic, on the producer Bacillus subtilis B3.
    Bhattacharyya P; Bose SK
    Indian J Med Res; 1967 Oct; 55(10):1025-9. PubMed ID: 4969876
    [No Abstract]   [Full Text] [Related]  

  • 9. A physicochemical study of an antifungal antibiotic from Bacillus subtilis.
    VAN VUUREN PJ; JOUBERT FJ; SERFONTEIN WJ
    Arch Biochem Biophys; 1961 Nov; 95():251-5. PubMed ID: 13924645
    [No Abstract]   [Full Text] [Related]  

  • 10. A comparison of the properties of penicillinase produced by Bacillus subtilis and Bacillus cereus with and without addition of penicillin.
    MANSON EE; POLLOCK MR; TRIDGELL EJ
    J Gen Microbiol; 1954 Dec; 11(3):493-505. PubMed ID: 13221770
    [No Abstract]   [Full Text] [Related]  

  • 11. [The characteristics of alirin B1--the basic component of a fungicidal preparation produced by the Bacillus subtilis 10-VIZR strain].
    Shenin IuD; Kruglikova LF; Kal'ko GN; Novikova II
    Antibiot Khimioter; 1995 May; 40(5):3-7. PubMed ID: 8534177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antifungal properties of various extracts of Bacillus subtilis (Tracy strain) obtained in the bacitracin recovery process.
    MOORE M; WOOLDRIDGE WE
    J Invest Dermatol; 1950 Apr; 14(4):265-81. PubMed ID: 15412279
    [No Abstract]   [Full Text] [Related]  

  • 13. Coproduction of surfactin and iturin A, lipopeptides with surfactant and antifungal properties, by Bacillus subtilis.
    Sandrin C; Peypoux F; Michel G
    Biotechnol Appl Biochem; 1990 Aug; 12(4):370-5. PubMed ID: 2119191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [OXIDATIVE PHOSPHORYLATION IN BAC. SUBTILIS AND BAC. MESENTERICUS].
    KOLCHINSKAIA ID; TINIANOVA NZ; DRYNDINA LP
    Mikrobiol Zh; 1964; 26():33-7. PubMed ID: 14348365
    [No Abstract]   [Full Text] [Related]  

  • 15. [Vital concurrence between microorganisms. II. Antagonistic effect of Bacillus subtilis].
    GUIDA VO
    Rev Bras Gastroenterol; 1955; 7(5-6):271-80. PubMed ID: 13310887
    [No Abstract]   [Full Text] [Related]  

  • 16. [Expression of N domain of chromogranin A in Bacillus subtilis and its antifungal activity].
    Li RF; Lou JX; Zhang TY
    Sheng Wu Gong Cheng Xue Bao; 2004 Mar; 20(2):274-8. PubMed ID: 15969121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microbial pentosanases. II. Some factors affecting the production of pentosanases by Bacillus pumilus and Bacillus subtilis.
    SIMPSON FJ
    Can J Microbiol; 1956 Feb; 2(1):28-38. PubMed ID: 13293582
    [No Abstract]   [Full Text] [Related]  

  • 18. Production of biosurfactant lipopeptides Iturin A, fengycin and surfactin A from Bacillus subtilis CMB32 for control of Colletotrichum gloeosporioides.
    Kim PI; Ryu J; Kim YH; Chi YT
    J Microbiol Biotechnol; 2010 Jan; 20(1):138-45. PubMed ID: 20134245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The first report of antifungal lipopeptide production by a Bacillus subtilis subsp. inaquosorum strain.
    Knight CA; Bowman MJ; Frederick L; Day A; Lee C; Dunlap CA
    Microbiol Res; 2018 Nov; 216():40-46. PubMed ID: 30269855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of citric acid on the growth of a variant of Bacillus subtilis.
    WIAME JM; BOURGEOIS S
    Nature; 1953 Aug; 172(4372):310-11. PubMed ID: 13087208
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.